Guardant Health
GH
#1003
Rank
โ‚ฌ21.19 B
Marketcap
157,94ย โ‚ฌ
Share price
1.75%
Change (1 day)
191.87%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: โ‚ฌ21.19 Billion

As of October 2026 Guardant Health has a market cap of โ‚ฌ21.19 Billion. This makes Guardant Health the world's 1003th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ21.19 B86.16%
2025โ‚ฌ11.38 B215.01%
2024โ‚ฌ3.61 B21.69%
2023โ‚ฌ2.97 B14.34%
2022โ‚ฌ2.59 B-71.07%
2021โ‚ฌ8.97 B-14.29%
2020โ‚ฌ10.47 B59.92%
2019โ‚ฌ6.55 B132.46%
2018โ‚ฌ2.81 B

End of Day market cap according to different sources

On Oct 4th, 2026 the market cap of Guardant Health was reported to be:

โ‚ฌ21.19 Billion
by Nasdaq info icon info icon
โ‚ฌ21.19 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Neogen
NEOG
โ‚ฌ2.35 B-88.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
โ‚ฌ52.54 B 147.90%๐Ÿ‡บ๐Ÿ‡ธ USA